CAMP
CAMP4 THERAPEUTICS CORPORATION
4.20
-0.13 (-3.00%)
52w low 2.90
7.75 high
26.8% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 350.00K | 652.00K | 3.50M | |
| Operating Expenses | 45.00M | 52.23M | 53.74M | 55.56M | |
| R&D | 34.77M | 40.62M | 38.82M | 38.20M | |
| SG&A | 10.23M | 11.61M | 14.92M | 17.36M | |
| Operating Income | -45.00M | -51.88M | -53.09M | -52.06M | |
| EBITDA | -44.12M | -50.20M | -51.39M | -50.42M | |
| Pretax Income | -44.19M | -49.29M | -51.79M | -80.40M | |
| Net Income | -44.19M | -49.29M | -51.79M | -80.40M | |
| EPS Diluted | -3.64 | -4.07 | -11.04 | -2.65 | |
| Diluted Shares | 12.12M | 12.12M | 4.69M | 30.38M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+436.5%